Dyadic International Inc
DYADIC ANNOUNCES THIRD QUARTER 2026 FINANCIAL RESULTS AND RECENT DEVELOPMENTS
Advances Commercialization, Expands Strategic Partnerships and Accelerates Biopharmaceutical Platform Validation
Company newsroom
NASDAQ:DYAI
1 releases
Advances Commercialization, Expands Strategic Partnerships and Accelerates Biopharmaceutical Platform Validation